Jiangsu, China

Ying Fan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Suzhou Alphamab Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying Fan. Retrieved from https://idiyas.com/inventor/ying-fan-m4m98bnt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ying Fan: Innovator in Monoclonal Antibody Development

Introduction

Ying Fan is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has led to the creation of a patent that addresses critical medical needs.

Latest Patents

Ying Fan holds a patent for a "Monoclonal Antibody Which Targets TFPI." This invention represents a significant advancement in therapeutic options for various medical conditions. The patent showcases his expertise and commitment to improving healthcare through innovative solutions. He has 1 patent to his name.

Career Highlights

Ying Fan is currently employed at Suzhou Alphamab Co., Ltd. This company is known for its focus on developing innovative biopharmaceuticals. His role at the company allows him to contribute to groundbreaking research and development in the field of monoclonal antibodies.

Collaborations

Ying Fan has collaborated with notable colleagues, including Ting Xu and Xiaoxiao Wang. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Ying Fan's contributions to the field of biotechnology, particularly through his patent on monoclonal antibodies, highlight his role as an innovator. His work at Suzhou Alphamab Co., Ltd. and collaborations with esteemed colleagues further emphasize his impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…